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CC BY-NC-ND license (http://creativeAbstract Objective: To investigate the mechanism by which hydroxyl safflower yellow A, an
active component of safflower (Carthamus tinctorius L.), promotes apoptosis in abnormal hu-
man umbilical vein endothelial cells (HUVECs).
Methods: Supernatant of BGC-823 was used to stimulate HUVECs to establish a model of
abnormal proliferation of HUVECs. After determining an ideal concentration of HSYA by MTT
assay, apoptosis was detected with flow cytometry and TUNEL assay. Mechanism of apoptosis
was assessed using quantitative real-time polymerase chain reaction, Western blot, and ELISA.
Results: A range of concentrations of HSYA inhibited proliferation and promoted apoptosis of
abnormal HUVECs. As the rate of apoptosis increased, mRNA expression of caspase-3 increased
whileexpressionofmutantp53decreased.HSYAhadnoeffectonFasgeneexpression.Analogously,
protein expression of Bax was increased while those of Bcl-2, Fas, and Fas-L were decreased.
Conclusions: HSYA appears to induce apoptosis of HUVECs with the stimulation of the supernatant
of tumor cells. The mechanism of apoptosis by HSYA may involve activation of the mitochondrial
apoptotic pathway and regulation of the expressions of Bcl-2, Bax, and p53.
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26 N. Si et al.IntroductionMalignant neoplasms are the second leading cause of mor-
tality worldwide after cardiovascular diseases.1 Common
anti-neoplastic drugs inhibit the growth of cancer cells or
kill the cells directly, but they are also toxic toward healthy
cells. For this reason research is transitioning toward new
types of anti-tumor drugs that are less toxic and more
targeted. Angiogenesis inhibitors are one class of drugs
under intense study as anti-neoplastic agents.
In the 1970s, Folkman put forward the notion that tumor
growth depends on angiogenesis.2 Vascular endothelial
cells (VECs) cover the inner surface of blood vessels and
constitute barriers of permeability of the vascular wall.
VECs provide tumor cells with at least 20 different growth
factor and anti-apoptosis factors3 Each VEC regulates the
proliferation of 50e100 tumor cells. Proliferation and
transformation of tumor cells can be inhibited if the pro-
liferation of VECs is constrained or their apoptosis is pro-
moted. Apoptosis of VECs is a complex system of links and
many pathways and is regulated by a series of genes and
their expression products. Pathways of apoptosis are mainly
caspase-dependent and -independent. The two commonly
described initiation pathways are extrinsic (or death re-
ceptor)4 and intrinsic (or mitochondrial).5 The caspase-
independent pathway is mainly regulated by the p53 gene.6
In Chinese medicine, herbs with traditional effect of
invigorating (promoting) blood circulation and transforming
stasis (removing blockage) are used to treat malignant tu-
mors.7 One such herb is safflower (Carthamus tinctorius
L.), used in Chinese medicine for menstrual disorders,
trauma, joint pain, and abdominal masses.8 Hydroxy saf-
flower yellow-A (HSYA), a water-soluble yellow quinoid
glycoside chalcone substance extracted from safflower,9 is
a primary active component in this herb.
Our previous study demonstrated that HSYA reduced the
number of blood vessels in chorioallantoic membrane of
chicken embryos (CAM), thus evidencing HSYAmay be a novel
inhibitor of angiogenesis.10 In a subsequent study, we found
that HSYA could promote apoptosis of abnormal human um-
bilical vein endothelial cells (HUVEC).11However, because the
specificmechanismof apoptosis remained unclear (Fig. 1),we
undertook this investigation to gain better understanding of
how HSYA brings about apoptosis in HUVECs.Figure 1 The apoptosis signaling pathways and the probable
targets of HSYA.Methods
Cell culture
Primary HUVEC derived from fresh umbilical cord (Depart-
ment of Obstetrics and Gynecology, ChinaeJapan Friendship
Hospital, Beijing) were incubated in M199 complete media
(Gibco, Grand Island, NY, USA) with 10% newborn calf serum
(Gibco), at 37C in humidified atmosphere with 5% CO2. Cells
were passaged within 24 hours after adherence and 80% were
recovered. Human gastric cancer BGC-823 cells (Cancer
Institute, Cancer Hospital of the Chinese Academy of Medical
Sciences, Beijing) were cultured under the same conditions.
The medium was changed after adherence and supernatants
were collected after 2 hours. The supernatants were used to
compound 50% BGC-823 with M199 complete media.MTT assay
HUVEC (0.5  105/mL) were plated in 96-well plates and
incubated at 37C and 5% CO2 for 6 hours. After removing
the supernatant, we added 100 mL 50% BGC-823 superna-
tant into the model group plates, 100 mL mixture of 50%
BGC-823 supernatant and different concentrations of HSYA
(National Institute for the Control of Pharmaceutical and
Biological Products, Beijing; purity >95%) were added into
the HSYA group plates, and 100 mL M199 was added to the
control group plates. The plates were then incubated for
20 hours at 37C, after which 10 mL MTT (5 mg/mL) was
added to each well. After incubation for 4 hours, 70 mL
supernatant was removed and 100 mL DMSO was added.
Absorbance was detected at 570 nm. The ideal concentra-
tion of HSYA was then selected to proceed to the next
steps.
Cell treatment and groups
HUVEC (4.0  104/mL) were plated in culture flasks and
incubated at 37C in 5% CO2 for 6 hours. They were then
divided into 3 groups: control group, consisting of HUVEC
with M199; model group, consisting of HUVEC with 50%
tumor supernatant; and HSYA group, consisting of model
group and 0.075 g/L HSYA. After incubation at 37C and 5%
CO2 for 20 hours, we observed cell status and collected the
cells to proceed with the following experiments.
Flow cytometry
Cell concentration was adjusted to 1.0  106/mL for each
of the 3 groups, harvested, and 1 mL 75% cold ethanol was
added to resuspend the cells. After centrifugation, cells
were resuspended in 1 mL of cold PBS, centrifuged at 4C,
1000 rpm for 10 minutes, and the supernatant discarded.
This process was performed twice. The cells were then
suspended in 200 mL of binding buffer, stained with propi-
dium iodide for 30 minutes in the dark at 4C. Afterward,
300 mL binding buffer was added and the cells analyzed by
flow cytometry (BD Biosciences, San Jose, CA, USA).
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After adjusting cell concentration to 3  105/mL for each of
the 3 groups, cells were fixed with freshly prepared para-
formaldehyde for 10 minutes, rinsed twice with PBS.
Apoptosis was determined using an in situ cell-death
detection kit (Roche, Indianopolis, IN, USA) according to
the manufacturer’s protocol.
Quantitative real-time polymerase chain reaction
Total RNA was extracted from frozen samples using Trizol re-
agent. Then 1% agarose gel electrophoresis was applied to
stimulate RNA integrity. RNA quality and quantity were
detected using a Unicam spectrophotometer (Thermo Scien-
tific, Waltham, MA, USA). Reverse transcription was per-
formed in a 20mL volumecontaining 3mg total RNA,Oligo (dT),
dNTPs, RNasin ribonuclease inhibitor, 5 reverse transcrip-
tase buffer, M-MLV reverse transcriptase, and nuclease-free
water. Real-time polymerase chain reaction (PCR) primers
used in the experiments are listed in Table. The final reaction
solution (20 mL) contained 1 ml primer, 10 mL Light Cycler Fast
Start DNA Master SYBR Green 1 (Roche), 2 ml cDNA, and 7 mL
nuclease-freewater.Cyclingparameterswere: 1 cycleat95C
for 3 minutes, followed by 45 cycles at 95C for 30 s, separate
annealing temperature for 40 seconds, and72C for 9 seconds.
Amplification and data acquisition were performed using the
Light Cycler 2.0 system (Roche). The cycle threshold (CT) was
recorded and the relative expression ofmRNA in every sample
was calculated with 266CT.
Western blot
Cells were digested with 0.025% trypsin, then centrifuged at
4C, 1000 rpm for 5 minutes. Cells were washed twice with
freshly-prepared PBS, then mixed with lysis buffer, that is,
radioimmunoprecipitation assay (RIPA) buffer containing
protease inhibitor. The solutionwas rotated for 10minutes on
ice and shaken every 5minutes to fully lyse the cells. The cells
were then centrifuged at 13000 rpm at 4C for 15 minutes to
separate out the protein. The collected protein was dena-
tured and resolved using SDS-PAGE kit (Bio-Rad, Hercules, CA,
USA), then electroblotted onto polyvinylidene difluoride
(PVDF) membranes. The membranes were blocked in 5%
nonfat driedmilk in tris-buffered saline and Tween 20 (TBS-T)
and incubated overnight separately with Bcl-2 or Bax primary
antibodies (1:4000; SantaCruzBiotechnology,Dallas,TX,USA)
on the shaker for 2 hours at room temperature and 4C. This
was followed by incubation with secondary antibodies
(1:8000; SigmaeAldrich, St. Louis, MO, USA) for 2 hours at
room temperature on the shaker. Specific protein bands were
detected by using electrogenerated chemiluminescenceTable The sequences and annealing temperatures of primers in
Gene Forward primer Reverse prim
Fas GCAACATCACCATGCAGATCA TGGCTTGTCA
Caspase-3 AGCATGGAAGAGGATTCTGGA AGGACCATCC
mt p53 ACTGTGGCTCTTGGTGCACTC CCCAATTGCT(ECL) reagents (Applygen Technologies, Beijing) and exposure
toX-rayfilm.Densitiesof specificbandswere scannedusingan
AlphaImager system (ProteinSimple, San Jose, CA). All results
were calculated in triplicate.
Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA) was performed
according to manufacturer’s protocol (Abcam, Cambridge,
MA,USA). Briefly, 100mLof samplewas added intoeachwell of
a 96-well plate. The plate was incubated at 37C for 2 hours.
The solution inside each well was poured by decanting. Then,
100 mL of working solution A was added to each well and the
plate was incubated for 1 hour at 37C. The solution inside
each well was decanted and discarded. Then, 100 mL of
working solution B was added to each well and the plate was
incubated for 1 hour at 37C.The solution insideeachwellwas
poured by decanting and discarded. This was followed by
adding 90 mL chromogenic substrate solution and developing
at 37C for 15 minutes in the dark. Finally, 50 mL of stop so-
lution was added to each well. Absorbance of each well was
read at 450 nm with a micro-plate reader.
Statistical analysis
Statistical analysis was performed using SPSS software
(version 16.0; IBM, Armonk, NY, USA). Data was expressed as
mean (SD). One-way ANOVA was used to compare the means
from multiple sets of parameters. Differences in means were
calculated using the least significant difference test. Differ-
ences were considered statistically significant when P< 0.05;
the exact P-values were shown unless P < 0.01.
Results
Cell proliferation
Cell proliferation was evaluated using the MTT assay. Under
inverted light microscopy, HUVECs appeared polygonal or
fusiform. Growth of abnormal HUVECs (Fig. 2B) was denser
than normal HUVECs (Fig. 2A), while growth of cells treated
with HSYA was clearly suppressed (Fig. 2C).
Inhibitory effects of HSYA on cell viability in
abnormal HUVECs
Results of the MTT assay showed that HUVECs proliferated
significantly with stimulation of BGC-823 supernatant
(P < 0.01; Fig. 3). Adding varying concentrations of HSYA
revealed that at 0.3 g/L, 0.15 g/L, 0.075 g/L, and 0.0375 g/





CATCTGCAAGT 53C 228 bp
CACTGTCTGTC 52C 280 bp
GGATATCTGGA 58C 240 bp
Figure 2 HUVECs were treated in groups and taken pictures with 100*. (A) HUVECs were treated with M199 media. (B) HUVECs
were treated with 50% BGC-823 supernatant. (C) HUVECs were treated with the same supernatant and 0.075 g/L HSYA.
Figure 3 HSYA inhibited the proliferation of HUVECs treated
with 50% BGC-823 supernatant. Control group: HUVECs with
M199 media. Model group: HUVECs with 50% BGC-823 super-
natant. HUVECs in all the other groups were treated with the
same supernatant and different concentrations of HSYA. MTT
assay was performed after treatment for 20 h. Model group vs
Control group, P < 0.05. Compared with Model group,
*P < 0.05, **P < 0.01.
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pronounced inhibitory effect (P < 0 .01; Fig. 3). For this
reason, we chose 0.075 g/L HSYA to perform the following
experiments.HSYA induction of apoptosis in abnormal HUVECs
To study the effect of HSYA on apoptosis, flow cytometry
and TUNEL assay were performed. Results of flow cytom-
etry revealed that the apoptotic rate (Fig. 4D) in the HSYA
group (Fig. 4C) was significantly increased compared withFigure 4 HSYA promoted the apoptosis of abnormal HUVECs. The
Model group (C) HSYA group (D) The analysis of apoptosis rate withthe model group (Fig. 4B). Results of the TUNEL assay
validated this (Fig. 5B vs. Fig. 5C). By observing and
counting the cells, we found that the number of abnormal
HUVECs was markedly increased (Fig. 5D).
mRNA expression of apoptotic factors mediated by
HSYA in abnormal HUVECs
Compared with the model group, HSYA had nearly no effect
on expression of Fas (Fig. 6B), while it decreased expression
of mutant-type (mt) p53 (Fig. 6C) and increased expression
of caspase-3 (Fig. 6A).
Protein expression of apoptotic factors mediated
by HSYA in abnormal HUVECs
Protein expressions of Bcl-2, Bax, Fas, and Fas-L were
detected by Western blot and ELISA. Expression of Bax was
significantly increased in the HSYA group (Fig. 7A, C), while
expressions of Bcl-2, Fas, and Fas-L were decreased
compared with the model group (Fig. 7B, C, D, E).
Discussion
Growth of vascular endothelial cells (VECs) is fundamental
to angiogenesis.12 The process is dependent on the balance
between signals that promote growth and those that induce
apoptosis. Inhibiting growth and inducing apoptosis of VECs
can prevent generation of tumor vessels and migration of
tumor cells.
Apoptosis was first put forward in 1972 by Kerr and col-
leagues.13,14 As described by Lowe and colleagues, “It is anapoptosis was detected by flow cytometry. (A) Control group (B)
PI staining. Compared with Model group, *P < 0.05.
Figure 5 The effects on Fas, mt p53 and Caspase-3 in mRNA level by HSYA. The number of apoptotic cells was detected by
TUNEL. (A) Control group (B) Model group (C) HSYA group (D) The analysis of the number of apoptotic cells. Compared with Model
group, **P < 0.01.
Figure 6 The effects on Fas, mt p53 and Caspase-3 in mRNA level by HSYA. (A) HSYA influenced the mRNA expression of Caspase-
3. (B) HSYA influenced the mRNA expression of Fas. (C) HSYA influenced the mRNA expression of mt p53. Compared with Model
group, *P < 0.05.
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physiological and pathological conditions.”15 The balance
between apoptosis and cell growth is the most basic pro-
cess, because of its impact on growth, development, ho-
meostasis, and the immune system.16Figure 7 The influence on the expression of related proteins by H
(A) The expression of Bax. (B) The expression of Bcl-2. (C) The relat
was measured by ELISA. (D) The expression of Fas. (E) The expressIn this study, we evaluated the effect of HSYA on pro-
liferation and apoptosis in abnormal HUVECs. Results of the
MTT assay indicated that HSYA inhibited proliferation of
abnormal HUVECs and that a range of concentrations of
HSYA promoted apoptosis. Thus, HSYA appears to inhibitSYA. The expression of Bax and Bcl-2 was measured by Western.
ive expression of Bax and Bcl-2. The expression of Fas and Fas-L
ion of Fas-L.
Figure 8 The locations of HSYA in apoptosis signaling path-
ways approved in this research.
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angiogenesis.
The apoptotic pathway mediated by death receptors is
an extrinsic pathway for programmed cell death (Fig. 8). A
typical death receptor is Fas. After it binds with Fas-L in the
cell membrane, Fas activates caspase-8, which in turn ac-
tivates caspase-3. This signaling cascade ends in cell death,
or apoptosis. The mitochondrial pathway, on the other
hand, is an intrinsic pathway for programmed cell death. It
involves the Bcl-2 protein family. Its members are divided
into proteins, such as Bax, which promote apoptosis and
proteins, such as Bcl-2, and suppress apoptosis. The bal-
ance between the anti-apoptotic and pro-apoptotic pro-
teins determines whether apoptosis can occur.17
Intracellular stress, such as hypoxia,18,19 can activate
expression of the Bcl-2 family of proteins. Once the cascade
is initiated, Bax causes mitochondria to release cytochrome
c (cyt c) while Bcl-2 attempts to inhibit release of cyt c. Cyt
c then activates caspase-9, which in turn activates other
downstream caspases, such as caspase-3, causing the DNA
to fragment and thus cell apoptosis.20 The p53 gene-
dependent pathway is yet another apoptotic cascade that
is caspase-independent. This pathway is mainly regulated
by the nucleus-residing protein p53, which is divided into
wild and mutational (mt) types. In our study, we detected
mt p53. The mechanism of apoptosis induced by mt p53 is
loss of the ability to combine with nucleus-specific DNA and
inability to bind with p53 binding protein or only weakly.14
Concurrently, mt p53 inhibits the activity of wild-type p53.
Finally, cells undergo malignant transformation.
From our results we discovered that mRNA expression of
caspase-3 was increased while that of mt p53 was
decreased in the HSYA group, compared with the model
group, indicating HSYA promotes expression of caspase-3
and inhibits that of mt p53. In another words, HSYA
impacted both the caspase-dependent and -independent
pathways. At the protein level, expression of Bax was
increased while expression of Bcl-2 was decreased with
HSYA treatment, demonstrating that HSYA appears to
regulate the function of Bax and Bcl-2 and promote the
mitochondrial apoptotic pathway. Neither results of PCR
nor ELISA assay demonstrated that HSYA had an effect on
Fas expression, indicating that HSYA had little effect on thedeath receptor pathway. Therefore, the mechanism by
which HSYA effects apoptosis may be through up-regulating
expression of Bax and caspase-3, and down-regulating
expression of Bcl-2 and mt p53. By means of a series of
effects, the cascade reaction of caspases is initiated,
resulting in signals for apoptosis entering the nucleus to
further to complete cell death (Fig. 8).
A limitation of this study is that despite the collective
results of experiments performed during this study pointing
to HSYA inducing apoptosis of HUVECs, we were unable to
assess whether activation of caspase-3 after adding HSYA
was mediated by the mitochondrial pathway or stimulated
directly by HSYA. Further research is needed to elucidate
this.
Conclusions
This study demonstrated that HSYA appears to induce
apoptosis of VECs, inhibit tumor angiogenesis, and ulti-
mately suppress tumor growth. The mechanism by which
this is accomplished may be the activation by HSYA of the
mitochondrial pathway in HUVECs and gene and protein
expressions of mutant-type p53, Bcl-2, Bax, and caspase-3.
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